Romain Marmot

Chief Business Officer - Voluntis, Inc.

[Romain Marmot @romain_marmot]

Great news for Voluntis: Jan Berger and Roberta Herman , M.D. have been appointed to our Board of Directors. https://t.co/T9QsedN0sU

[Voluntis @Voluntis]

So proud of our teams and of our work with @AstraZeneca!

[Romain Marmot @romain_marmot]

Continued partnership with AstraZeneca. #digitaltherapeutics can make a difference in oncology. https://t.co/D0emn6WHdT

[Romain Marmot @romain_marmot]

Roche and Voluntis strengthen their partnership to develop Digital Therapeutics in oncology. https://t.co/oEzUo74jNM https://t.co/un9OMEaFEM

[Romain Marmot @romain_marmot]

Life sciences panorama is next week. You can still register here:  https://t.co/5OuUftXe26 https://t.co/I0UZDle5MG

[Romain Marmot @romain_marmot]

Roche's just acquired Flatiron Health for $1.9bn. What do other pharma leaders think about that? We'll have a chance to get Heather Bell and Jeremy Sohn's perspective on what digital health means for Sanofi and Novartis during the…https://t.co/MDtELyjckm https://t.co/erV4gZYgws

[Romain Marmot @romain_marmot]

The Economist on the Digital Therapeutics Alliance and Voluntis: https://t.co/2oWmZ9FDzI https://t.co/y0Sj9S4ADv

[Romain Marmot @romain_marmot]

Ellie Strock, on the potential of digital therapeutics in oncology. https://t.co/7bPWVvnYFQ

[Romain Marmot @romain_marmot]

@dtx_alliance: digital therapeutics alliance w/@AkiliLabs @OmadaHealth @PropellerHealth @WellDoc @Voluntis: join us! https://t.co/oMg1JVHHll

[Romain Marmot @romain_marmot]

Sanofi and Voluntis announce a global partnership for T2 Diabetes.
https://t.co/pkkagglCT1

[Voluntis @Voluntis]

Come see me talk about successful #diabetes apps today at #2017DDC with @GlookoInc @WellDoc @UCSF & @VanderbiltNurse ! - Pierre

[Romain Marmot @romain_marmot]

Livongo is a great company. Very innovative products and services for people with diabetes. I am glad to announce th…https://t.co/wYXBTkSz8p

[Romain Marmot @romain_marmot]

Congratulations to the team - a lot of hard work. Excited to offer Insulia to T2D patients and providers in the US and in Europe! https://t.co/9ER37ySMjt

[Voluntis @Voluntis]

@Voluntis gets FDA Clearance & CE Mark For Insulia App Supporting Type 2 #Diabetes Patients Treated w/ Basal Insulin https://t.co/eoqWmrQCEG

[Romain Marmot @romain_marmot]

Speaking this morning about life sciences & digital convergence at @pharmamedtech2016. https://t.co/C804eVcjMt

[Romain Marmot @romain_marmot]

Great to share thoughts on life sciences & digital convergence today at #pharmamedtech2016. Thx Sarah Hogan & MWE for inviting me to speak.

[Voluntis @Voluntis]

@Voluntis is at #chealth16! Come visit us at the startup pavilion and learn about our solutions & how we can add value to your organization.

[Voluntis @Voluntis]

Voluntis helps US patients make the most of their medication through companion software! https://t.co/3K6RkWCLWO #CreativeNextUS

[Romain Marmot @romain_marmot]

Creating Medical Apps That Actually Get Used https://t.co/a28ts7Gzu4 via @docweighsin

[Consulate of France in Boston @FranceinBoston]

@sbancel @moderna_tx CEO sharing his disruptive vision of patient care @MassChallenge @FACCNE #CafeEntrepreneurs

[Romain Marmot @romain_marmot]

AstraZeneca and Voluntis partner to build first therapeutic companion app for ovarian cancer. https://t.co/3Qtsr5WNwU